1 Protective Effects of Serotonin and its Derivatives, N-Feruloylserotonin and N-(p-Coumaroyl) Serotonin, Against Cisplatin-Induced Renal Damage in Mice.

2 Author Correction: LOTUS domain protein MARF1 binds CCR4-NOT deadenylase complex to post-transcriptionally regulate gene expression in oocytes.

3 High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment.

4 More than just a pressure relief valve: physiological roles of volume-regulated LRRC8 anion channels.

5 AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.

6 The Positive Fate of Biochar Addition to Soil in the Degradation of PHBV-Silver Nanoparticle Composites.

7 The dietary isoflavone daidzein mitigates oxidative stress, apoptosis, and inflammation in CDDP-induced kidney injury in rats: Impact of the MAPK signaling pathway.

8 Impact of garlic (Allium sativum) oil on cisplatin-induced hepatorenal biochemical and histopathological alterations in rats.

9 Chemotherapy in the definitive management of oral cancers: Where do we stand today?

10 Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy.

11 Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?

12 [Mono- and Binuclear Dinitrosyl Iron Complexes with Thiol-containing Ligands in Various Biosystems].

13 Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study.

14 Short-Term Diet Restriction but Not Alternate Day Fasting Prevents Cisplatin-Induced Nephrotoxicity in Mice.

15 Exogenous follistatin administration ameliorates cisplatin-induced acute kidney injury through anti-inflammation and anti-apoptosis effects.

16 effects of alprostadil on respiratory parameters and hemodynamics of newborns with persistent pulmonary hypertension

17 zataria multiflora ameliorates testicular and spermatological damages induced by cisplatin in mice model

18 phytochemical evaluation of roots of plumbago zeylanica l. and assessment of its potential as a nephroprotective agent

19 december 2013 pulmonary case of the month: natural progression

20 paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract

21 low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer

22 targeting nuclear factor-kappa b to overcome resistance to chemotherapy.

23 hypoxia potentiates the capacity of melanoma cells to evade cisplatin and doxorubicin cytotoxicity via glycolytic shift

24 synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus

25 inhibition of mitochondrial division attenuates cisplatin-induced toxicity in the neuromast hair cells

26 synergism between dipyridamole and cisplatin in human breast cancer cells in vitro

27 a model for prediction of cisplatin induced nephrotoxicity by kidney weight in experimental rats

28 Pomegranate Juice Extract Decreases Cisplatin Toxicity on Peripheral Blood Mononuclear Cells.

29 beneficial effects of fermented black ginseng and its ginsenoside 20(s)-rg3 against cisplatin-induced nephrotoxicity in llc-pk1 cells

30 polysaccharide from sepia esculenta ink and cisplatin inhibit synergistically proliferation and metastasis of triple-negative breast cancer mda-mb-231 cells

31 a phase iii randomized study comparing a chemotherapy with cisplatin and etoposide to a etoposide regimen without cisplatin for patients with extensive small-cell lung cancer

32 optimization of a hplc procedure for simultaneous determination of cisplatin and the complex cis,cis,trans-diamminedichlorodihydroxoplatinum(iv) in aqueous solutions

33 activation of chk1 in supporting cells indirectly promotes hair cell survival

34 protective effect of ginsenoside rh3 against anticancer drug-induced apoptosis in llc-pk1 kidney cells

35 potential therapeutic strategies for non - muscle invasive bladder cancer based on association of intravesical immunotherapy with p-mapa and systemic administration of cisplatin and doxorubicin

36 Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors

37 Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity.

38 Preventive Effect of the Herbal Preparation, HemoHIM, on Cisplatin-Induced Immune Suppression

39 A thermo-responsive alginate nanogel platform co-loaded with gold nanoparticles and cisplatin for combined cancer chemo-photothermal therapy

40 Antioxidant Effects of L. Attenuate the Anxiogenic Effect of Cisplatin in Rats.

41 D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics

42 Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1

43 Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment

44 A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo

45 Balloon-Occluded Trans-Arterial Chemoembolization Technique with Alternate Infusion of Cisplatin and Gelatin Slurry for Small Hepatocellular Carcinoma Nodules Adjacent to the Glisson Sheath

46 HIF-1 dependent reversal of cisplatin resistance via anti-oxidative nano selenium for effective cancer therapy

47 ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity.

48 Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer

49 Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma

50 Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells

51 Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis.

52 Doxorubicin/Cisplatin-Loaded Superparamagnetic Nanoparticles As A Stimuli-Responsive Co-Delivery System For Chemo-Photothermal Therapy.

53 Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.

54 Doxorubicin/Cisplatin-Loaded Superparamagnetic Nanoparticles As A Stimuli-Responsive Co-Delivery System For Chemo-Photothermal Therapy

55 Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).

56 Chemically Modified Carbon Nanohorns as Nanovectors of the Cisplatin Drug: A Molecular Dynamics Study.

57 The Protective Role of Galium Aparine on Cisplatin – Induced Nephrotoxicity in Male Rats

58 Lovastatin protects against cisplatin-induced hearing loss in mice.

59 RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence

60 Proximal tubule cyclophilin D regulates fatty acid oxidation in cisplatin-induced acute kidney injury.

61 Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy.

62 A rare entity: Recurrent cisplatin-induced bradycardia

63 Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice

64 Arctigenin enhances the sensitivity of cisplatin resistant colorectal cancer cell by activating autophagy

65 A rare entity: Recurrent cisplatin-induced bradycardia

66 Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats

67 Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma

68 Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice

69 the correlation between the up-regulation of hsp90  and drug resistance to cisplatin in lung cancer cell line

70 efficacy and safety of paclitaxel, ifosfamide and cisplatin as first-line treatment on patients with intermediate- or poor-risk advanced testicular cancer

71 potential implications of grp58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy

72 cisplatin-associated ototoxicity: a review for the health professional

73 nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma

74 complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with cisplatin and radiotherapy

75 metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in nci-h460 human lung cancer cells

76 sensitization of cervical cancer cells to cisplatin by genistein: the role of nfb and akt/mtor signaling pathways

77 cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment

78 use of labelled cisplatin obtained by direct irradiation in a preliminary biodistribution study

79 cisplatin in 5% ethanol eradicates cisplatin-resistant lung tumor by killing lung cancer side population (sp) cells and non-sp cells

80 cisplatinum and taxol induce different patterns of p53 phosphorylation

81 radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma 

82 combination of gemcitabine and carboplatin in urothelial cancer patients unfit for cisplatin due to impaired renal or cardiac function

83 evaluation of the efficacy and toxicity of protocol cisplatin, 5-fluorouracil, leucovorin compared to protocol fluorouracil, doxorubicin and mitomycin c in locally advanced and metastatic gastric cancer

84 new therapeutic concept of nad redox balance for cisplatin nephrotoxicity

85 xiao-ai-ping, a tcm injection, enhances the antigrowth effects of cisplatin on lewis lung cancer cells through promoting the infiltration and function of cd8+ t lymphocytes

86 the potential role of azadirachta indica treatment on cisplatin-induced hepatotoxicity and oxidative stress in female rats

87 the protective effect of naringenin-oxime on cisplatin-induced toxicity in rats

88 matricaria chamomilla attenuates cisplatin nephrotoxicity

89 alterations of phosphoproteins in nci-h526 small cell lung cancer cells involved in cytotoxicity of cisplatin and titanocene y

90 the protective effect of theophyline in cisplatin nephrotoxicity

91 changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats

92 timp3 overexpression improves the sensitivity of osteosarcoma to cisplatin by reducing il-6 production

93 ototoxicity in children receiving cisplatin chemotherapy

94 hypoxia-induced cisplatin resistance in non-small cell lung cancer cells is mediated by hif-1α and mutant p53 and can be overcome by induction of oxidative stress

95 Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors

96 Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice

97 Chemotheraphy with gemcitabine and cisplatin in a hemodialysis patient with metastatic urothelial carcinoma

98 Combination of hedyotis corymbosa L. and tinospora crispa ethanolic extract increase cisplatin cytotoxicity on T47D breast cancer cells

99 Combination of cisplatin, Hedyotis corymbosa L. and Tinospora crispa extracts as a new therapy for breast cancer cells 4T1 through in vitro induction and cell cycle modulation

100 Flammulina Velutipes polysaccharides ameliorate cisplatin-induced acute kidney injury in mice via regulation of gut microbiota and Ferroptosis pathway

101 Extracellular vesicles therapy alleviates cisplatin-ınduced testicular tissue toxicity in a rat model.

Keyword Connections

Journals

Research Groups

Bibliographies